Difference between calculated and direct-measured low-density lipoprotein cholesterol in subjects with diabetes mellitus or taking lipid-lowering medications

被引:14
|
作者
Choi, Su-Yeon [2 ]
Park, Hyo Eun [2 ]
Kim, Min-Kyung [2 ]
Shin, Chan Soo [2 ]
Cho, Sang-Heon [2 ]
Oh, Byung-Hee [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Syst Gangnam Ctr, Seoul 135984, South Korea
关键词
Low-density lipoprotein cholesterol; Friedewald formula; Diabetes mellitus; Triglyceride; Community-based study; CORONARY-HEART-DISEASE; ASSAY; RISK;
D O I
10.1016/j.jacl.2011.12.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: We evaluated factors that caused differences between calculated low-density lipoprotein cholesterol (C-LDL-C) and direct-measured LDL-C (D-LDL-C) and compared them in subjects with diabetes mellitus (DM) or taking lipid-lowering medications. METHODS: 21,452 subjects (9,177 women, 12,275 men; 8.1% with DM and 8.5% on lipid-lowering medications) were included in the analysis. Participants were classified into 3 groups, i.e., group 1: the subjects without DM and not on lipid-modifying drugs (n = 18,287), group 2: without DM and on lipid-modifying drugs (n = 1,423), and group 3: with DM (n = 1,742). LDL-C concentrations were either directly measured by a homogenous method or calculated by Friedewald formula. RESULTS: There was a significant correlation between C-LDL-C and D-LDL-C (r = 0.966, P < .001). The absolute values of the differences between two LDL-C values were 7.0 +/- 6.2 mg/dl and 6.6 +/- 7.3% (6.6 +/- 5.9 mg/dl and 6.0 +/- 6.5%, 8.8 +/- 6.7 mg/dl and 9.1 +/- 9.7%, and 10.1 +/- 7.3 mg/dl and 10.7 +/- 10.1% in group 1, 2, and 3 respectively, P < .001). The subjects with the absolute value of the differences of LDL-C >= 10% was 20.2% (17.3%, 31.3%, and 41.1% in group 1, 2, and 3 respectively, P < .001). In the multiple logistic regression analysis, high triglyceride (>= 150 mg/dl), low high-density lipoprotein cholesterol (HDL-C) (<40 mg/dl), male gender, obesity (body mass index >= 25 kg/m(2)), DM and taking lipid-lowering drugs were significant associated with high LDL-differences (the absolute value of the differences >= 10% or >= 10 mg/dl). CONCLUSION: D-LDL-C was generally higher by 5 mg/dl or 5% than C-LDL-C. The differences C-LDL-C and D-LDL-C were higher in subjects with DM and on lipid-lowering medications. Male gender, high triglyceride, low HDL-C, and obesity were also associated with the greater differences between C-LDL-C and D-LDL-C. (C) 2012 National Lipid Association. All rights reserved.
引用
收藏
页码:114 / 120
页数:7
相关论文
共 50 条
  • [11] Effects of Simvastatin and Ezetimibe in Lowering Low-Density Lipoprotein Cholesterol in Subjects with Type 1 and Type 2 Diabetes Mellitus
    Ciriacks, Kevin
    Coly, Gerard
    Krishnaswami, Shanthi
    Patel, Shailendra B.
    Kidambi, Srividya
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (02) : 84 - 90
  • [12] Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome
    Ferrieres, Jean
    Lautsch, Dominik
    Bramlage, Peter
    Horack, Martin
    Baxter, Carl A.
    Ambegaonkar, Baishali
    Toth, Peter P.
    Poh, Kian-Keong
    De Ferrari, Gaetano Maria
    Gitt, Anselm K.
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2020, 113 (10) : 617 - 629
  • [13] The Future of Low-Density Lipoprotein Cholesterol in an Era of Nonfasting Lipid Testing and Potent Low-Density Lipoprotein Lowering
    Farukhi, Zareen
    Mora, Samia
    CIRCULATION, 2018, 137 (01) : 20 - 23
  • [14] Correlations between Direct and Calculated Low-Density Lipoprotein Cholesterol Measurements in Children and Adolescents
    Alouffi, Sultan
    Khan, Mohd Wajid Ali
    Alotabi, Nawaf
    Alsuggyair, Amal
    Alhassan, Ikram
    Al Alwan, Ibrahim
    Al Banyan, Esam
    Al-Twaijri, Yasmin A.
    Tamim, Hani
    Al-Hussein, Fahad
    Aljasser, Salih
    Alfwaz, Hanan
    Tamimi, Waleed
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (06)
  • [15] HOW DIFFERENT CAN DIRECT AND CALCULATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL BE?
    Farinha, R.
    Ramos, E.
    Severo, M.
    Guimaraes, J. T.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S299 - S299
  • [16] Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics
    Chua, Yung-An
    Nazli, Sukma Azureen
    Rosman, Azhari
    Kasim, Sazzli Shahlan
    Ibrahim, Khairul Shafiq
    Radzi, Ahmad Bakhtiar Md
    Kasim, Noor Alicezah Mohd
    Nawawi, Hapizah
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (10) : 1317 - 1326
  • [17] The variability of measured and calculated low-density lipoprotein (LDL) cholesterol in statin-treated diabetes patients
    Kilpatrick, Eric S.
    Kallner, Anders
    Atkin, Stephen L.
    Sathyapalan, Thozhukat
    ANNALS OF CLINICAL BIOCHEMISTRY, 2024,
  • [18] Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes
    Wägner, AM
    Ordóñez-Llanos, J
    Jorba, O
    Pérez, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (11): : 1516 - 1516
  • [19] Performance of Calculated and Directly Measured Low-Density Lipoprotein Cholesterol in a Pediatric Population
    Roper, Stephen M.
    Cao, Jing
    Tam, Estella
    Devaraj, Sridevi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 148 (01) : 42 - 48
  • [20] Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula
    Jun, Kyung Ran
    Park, Hae-il
    Chun, Sail
    Park, Hlyosoon
    Min, Won-Ki
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (03) : 371 - 375